INSERM U932, Institut Curie, Paris, France.
Front Immunol. 2019 Jan 28;10:41. doi: 10.3389/fimmu.2019.00041. eCollection 2019.
Cross-priming refers to the induction of primary cytotoxic CD8 T cell responses to antigens that are not expressed in antigen presenting cells (APCs) responsible for T cell priming. Cross-priming is achieved through cross-presentation of exogenous antigens derived from tumors, extracellular pathogens or infected neighboring cells on Major Histocompatibility Complex (MHC) class I molecules. Despite extensive research efforts to understand the intracellular pathways involved in antigen cross-presentation, certain critical steps remain elusive and controversial. Here we review recent advances on antigen cross-presentation, focusing on the mechanisms involved in antigen export to the cytosol, a crucial step of this pathway.
交叉呈递是指诱导对不在负责 T 细胞起始的抗原呈递细胞 (APC) 中表达的抗原产生主要细胞毒性 CD8 T 细胞应答。交叉呈递是通过将源自肿瘤、细胞外病原体或受感染邻近细胞的外源抗原在主要组织相容性复合体 (MHC) Ⅰ类分子上交叉呈递来实现的。尽管人们进行了广泛的研究努力来理解抗原交叉呈递所涉及的细胞内途径,但某些关键步骤仍然难以捉摸且存在争议。在这里,我们综述了抗原交叉呈递的最新进展,重点介绍了该途径中涉及抗原向细胞质输出的机制,这是该途径的关键步骤。